MoCRA 2025 Complete Guide:
What Every Brand Needs to Know
The Modernization of Cosmetics Regulation Act (MoCRA) is the most significant expansion of FDA authority since 1938. Here is your roadmap to compliance.
Key Deadlines for 2025
July 1, 2024 (Past)
Original deadline for Facility Registration & Product Listing (Enforcement discretion applied until late 2024).
January 1, 2025
Full enforcement of Registration & Listing. FDA begins inspections for Safety Substantiation records.
December 29, 2025
Deadline for GMP (Good Manufacturing Practices) rule finalization.
1. Facility Registration
Every facility that manufactures or processes cosmetic products for distribution in the US must register with the FDA. This applies to both domestic and foreign facilities.
Key Difference from Old Rules: This is now mandatory. Previously, the VCRP program was voluntary. If you use a contract manufacturer (CM), you must ensure they are registered, or you cannot legally sell your product.
2. Product Listing
Brands must list each cosmetic product with the FDA, including its ingredients and the facility where it was made. This listing must be updated annually.
3. Safety Substantiation (Critical)
This is the most technically demanding part of MoCRA. Brands must maintain records supporting that their products are safe.
What counts as "Adequate Substantiation"?
The FDA does not prescribe specific tests, but industry standard (and expected) data includes:
- Microbiological Testing (USP 61/62)
- Preservative Efficacy Testing (USP 51)
- Stability Testing (Shelf Life)
- Toxicological Risk Assessment (TRA)
Relying solely on raw material safety data sheets (SDS) is no longer sufficient for finished product safety substantiation.
4. Adverse Event Reporting
You must now report "serious adverse events" to the FDA within 15 business days. You must also keep records of all adverse events (even non-serious ones) for 6 years (or 3 years for small businesses).